Wellington Management Group LLP Sells 1,219,908 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Wellington Management Group LLP has reduced its stake in HCA Healthcare by 18.9%, selling 1,219,908 shares to hold approximately 5.2 million shares, valued at about $1.81 billion.
• Several large investors are increasing their positions in HCA Healthcare, with GAMMA Investing LLC raising its stake by an extraordinary 40,527.3% during the first quarter.
• HCA Healthcare's stock is currently trading at $395.83, reflecting a modest increase of 0.6%, with a market capitalization of $92.62 billion and a recent quarterly EPS of $6.84 that beat expectations.

Wellington Management Group LLP cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 18.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,242,431 shares of the company's stock after selling 1,219,908 shares during the period. Wellington Management Group LLP owned about 2.18% of HCA Healthcare worth $1,811,522,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Capital World Investors raised its stake in shares of HCA Healthcare by 0.7% during the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company's stock worth $878,975,000 after purchasing an additional 19,121 shares during the period. Northern Trust Corp raised its stake in shares of HCA Healthcare by 12.4% during the 4th quarter. Northern Trust Corp now owns 2,017,971 shares of the company's stock worth $605,694,000 after purchasing an additional 223,248 shares during the period. Nuveen Asset Management LLC raised its stake in shares of HCA Healthcare by 4.5% during the 4th quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company's stock worth $560,011,000 after purchasing an additional 81,105 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after purchasing an additional 587,036 shares during the period. Finally, GAMMA Investing LLC raised its stake in shares of HCA Healthcare by 40,527.3% during the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock worth $5,887,850,000 after purchasing an additional 1,699,713 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

Shares of NYSE HCA traded up $0.61 during midday trading on Friday, hitting $404.87. 1,081,188 shares of the company's stock were exchanged, compared to its average volume of 1,431,386. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The company has a market cap of $94.74 billion, a price-to-earnings ratio of 17.02, a PEG ratio of 1.27 and a beta of 1.39. The business's fifty day moving average price is $373.91 and its two-hundred day moving average price is $353.90.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.HCA Healthcare's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 12.11%.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on HCA. Barclays decreased their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a report on Monday, July 28th. Wells Fargo & Company decreased their price objective on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. Bank of America lowered HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a report on Wednesday, July 16th. Robert W. Baird lifted their price objective on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. Finally, Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $398.58.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.